This study reports how P63 isoforms, ∆NP63α or TAP63α, play distinct functions during endochondral bone formation in two novel mouse models. These original findings will significantly advance our knowledge of understanding the mechanisms of P63 upon skeletal development and diseases. P63 belongs to the P53 tumor suppressor gene family. P63 isoforms (TAP63 or ∆NP63-α, -β, and -γ) are known to play important roles in cancer and development. Previous studies have shown that p63 null mice die at birth and have truncated limbs, while mutations in human P63 cause several skeletal syndromes that also show limb and digit abnormalities, suggesting its essential role in long bone development. Indeed, we observed increased level of p63 transcript in a cell model of chondrocyte maturation. To investigate the in vivo role of P63 upon endochondral bone formation, we have established transgenic mouse lines in which HA-and Flag-tagged ∆NP63α or TAP63α each is driven by the hypertrophic chondrocyte-specific Col10a1 regulatory elements. While no obvious abnormalities were shown in Col10a1-∆NP63α transgenic mice, skeletal staining of Col10a1-TAP63α mice at either embryonic day 17.5 (E17.5) or postnatal day 1 (P1) did show accelerated ossification in long bone, digit and tail bones compared to their wild-type littermates, suggesting distinct function of P63 isoforms during skeletal development. We also detected decreased level of Sox9 and Bcl-2 transcripts in Col10a1-TAP63α transgenic mouse limbs. Further immunohistochemical analysis confirmed the decreased Sox9 expression in the proliferative and hypertrophic zone of these mice. Together, our results suggest a role of TAP63α upon early skeletal development. TAP63a may promote endochondral ossification through interaction with genes relevant to chondrocyte maturation/apoptosis.
Generation and phenotypic analysis of transgenic mice
The DNA fragment containing the entire transgenic cassettes was released for transgenic microinjection in the Transgenic Production Service center at the University of Illinois at Chicago. Transgenic founders were genotyped by PCR amplification using HA-or Flag-tag and P63 cDNA specific primers. Alcian Blue and Alizarin Red staining and real-time RT-PCR analysis was performed to analyze the mouse phenotypes of transgenic mice at E17.5 and P1 stage and compared to their wild-type littermate controls.
RESULTS:
Col10a1-∆NP63α and Col10a1-TAP63α transgenic mice:
The previously reported hypertrophic chondrocyte-specific Col10a1 distal promoter and a shorter Col10a1 basal promoter (-220 to +45 bp) elements (Zheng et al., 2009 ) were used to generate P63-expressing transgenic constructs. A HA-and a Flag-tag at either 5'-or 3'-end were cloned in-frame with human ΔNP63α and TAP63α cDNA respectively (Figure 1 , top panel). PCR genotyping using human P63 and HA-or Flag fragment specific primers indicated that we have successfully generated three Col10a1-ΔNP63α transgenic founders (Figure 1 , bottom, left, lanes 10, 18, and 25) and four Col10a1-TA63α transgenic founders (Figure 1 , bottom, right, lanes 33, 52, 54, and 72).
Accelerated ossification in Col10a1-TAP63α transgenic mice:
We have performed phenotypic analysis of mice from Col10α1-ΔNP63α transgenic mouse lines at both E17.5 and P1 stages by alcian blue and alizaring red staining) and histological analysis. No obvious skeletal abnormalities were observed between TG and WT littermates (data not shown). Meanwhile, alcian blue and alizarin red staining suggested accelerated ossification in two lines of the Col10α1-TAP63α mice at both E17.5 (Figure 2, A) and the P1 (Figure 2, B) stages compared to WT littermate controls. Notice the more intensive alizarin red staining indicating advanced ossification in the whole skeleton (A1/B1), phalanges/digits (A2/B2), metacarsals/digits (A3/B3), and tail bones (A4/B4). The TG mice of Col10α1-TAP63α mouse lines 52 and 72 showed more ossified caudal vertebrates than that of WT littermates (p<0.05), while no difference was observed in line 33 (p>0.05, B5).
Expression profiling of Col10α1-TAP63α transgenic mice:
Total RNAs from both TG and WT mouse limbs of Col10α1-TAP63α lines were prepared and reversely transcribed for expression analysis using quantitative real-time RT-PCR approach. We detected significant reduction of Bcl-2 and Sox9 (n = 7, p < 0.05) transcripts in TG mice of lines 52 and 72 compared to the WT littermates, while the mRNA level of Bax, Col10a1 and Runx2 in TG mice is similar to that of WT controls (Figure 3, left) . Decreased Sox9 expression was also observed in the proliferative and hypertrophic zone of proximal femur in TG mice by immunostaining using anti-Sox9 antibody (data not shown).
SUMMARY:
We have successfully generated transgenic mice over expressing ΔNP63a or TAP63a in hypertrophic chondrocytes using the cell-specific Col10a1 control elements. Our preliminary results suggest that the Col10a1-TAP63a mice show accelerated ossification by skeletal staining, while no obvious skeletal abnormalities were observed in the Col10a1-ΔNP63a mice, suggesting distinct function of P63 isoforms on bone formation. Based on the phenotypic findings and the expression profiling of Col10α1-TAP63α mice, we surmise that selectively targeting TAP63α overexpression in hypertrophic chondrocytes results in downregulation of Bcl-2 and Sox9. This will lead to accelerated chondrocyte apoptosis or maturation and subsequently, enhanced endochondral ossification. Sox9 downregulation may release its inhibition on Runx2 function and therefore, promote bone formation (Figure 3, right) . 
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